Renato De Fanti

CHF6001 I: A Novel Highly Potent and Selective Phosphodiesterase 4 Inhibitor with Robust Anti-Inflammatory Activity and Suitable for Topical Pulmonary Administration

Nadia Moretto, Paola Caruso, Raffaella Bosco et al. · Journal of Pharmacology and Experimental Therapeutics · 2015 · 72 citations

Novel Class of Benzoic Acid Ester Derivatives as Potent PDE4 Inhibitors for Inhaled Administration in the Treatment of Respiratory Diseases

Elisabetta Armani, Gabriele Amari, Andrea Rizzi et al. · Journal of Medicinal Chemistry · 2014 · 47 citations · Full text

Asthma, Pharmaceutical Science, Inflammatory Lung Disease +19

Discovery and Optimization of Thiazolidinyl and Pyrrolidinyl Derivatives as Inhaled PDE4 Inhibitors for Respiratory Diseases

Laura Carzaniga, Gabriele Amari, Andrea Rizzi et al. · Journal of Medicinal Chemistry · 2017 · 21 citations · Full text

Pharmaceutical Science, Inflammatory Lung Disease, Phosphodiesterase 4 +18

Synthesis and anticonvulsant activity of a class of 2-amino 3-hydroxypropanamide and 2-aminoacetamide derivatives

Eleonora Ghidini, Maurizio Delcanale, Renato De Fanti et al. · Bioorganic & Medicinal Chemistry · 2006 · 19 citations

Medicinal Chemistry, 2-Aminoacetamide Derivatives, Medicine +3

Discovery of M₃ Antagonist-PDE4 Inhibitor Dual Pharmacology Molecules for the Treatment of Chronic Obstructive Pulmonary Disease

Elisabetta Armani, Andrea Rizzi, Carmelida Capaldi et al. · Journal of Medicinal Chemistry · 2021 · 10 citations · Full text

Pharmaceutical Science, Inflammatory Lung Disease, Lung Inflammation +19